Nondigested pro-IL-12 showed 10-fold less activity than MMP14-digested pro-IL-12 in vitro, yet injection of pro-IL-12 achieved tumor suppression and reduced adverse effects in mice [54]. This evidence concerns the gene MMP14 and neoplasm.